137 related articles for article (PubMed ID: 35503256)
1. Clear Cell Papillary Renal Cell Tumors: A Study of 42 Tumors with Emphasis on the Fibrous Capsule, Cystic Component, and GATA3 Immunohistochemistry.
da Paz AR; de Souza MF; Santana CMM; Athanazio DA
Int J Surg Pathol; 2023 Feb; 31(1):38-45. PubMed ID: 35503256
[TBL] [Abstract][Full Text] [Related]
2. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
Mantilla JG; Antic T; Tretiakova M
Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
[TBL] [Abstract][Full Text] [Related]
4. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
[TBL] [Abstract][Full Text] [Related]
5. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
6. GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma.
Liu Y; Dong Y; Gu Y; Xu H; Fan Y; Li X; Dong L; Zhou L; Yang X; Wang C
Ann Diagn Pathol; 2022 Oct; 60():152007. PubMed ID: 35841867
[TBL] [Abstract][Full Text] [Related]
7. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G
Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823
[TBL] [Abstract][Full Text] [Related]
8. Distal Tubular Hyperplasia: A Proposal for a Unique Form of Renal Tubular Proliferation Distinct From Papillary Adenoma.
Williamson SR; Al-Obaidy KI; Cheng L; Smith SC; Cox RM; McKenney JK; Gokden N; Phillips CL; Giannico GA; Gallan AJ; Przybycin CG; Grignon DJ
Am J Surg Pathol; 2021 Apr; 45(4):516-522. PubMed ID: 33560656
[TBL] [Abstract][Full Text] [Related]
9. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases.
Peckova K; Martinek P; Pivovarcikova K; Vanecek T; Alaghehbandan R; Prochazkova K; Montiel DP; Hora M; Skenderi F; Ulamec M; Rotterova P; Daum O; Ferda J; Davidson W; Ondic O; Dubova M; Michal M; Hes O
Ann Diagn Pathol; 2017 Feb; 26():23-30. PubMed ID: 28038707
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
12. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract][Full Text] [Related]
13. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
Chang A; Brimo F; Montgomery EA; Epstein JI
Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
[TBL] [Abstract][Full Text] [Related]
14. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
15. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
Caliò A; Marletta S; Brunelli M; Pedron S; Portillo SC; Segala D; Bariani E; Gobbo S; Netto G; Martignoni G
Virchows Arch; 2022 Dec; 481(6):877-891. PubMed ID: 35980471
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.
Williamson SR; Hornick JL; Eble JN; Gupta NS; Rogers CG; True L; Grignon DJ; Cheng L
Hum Pathol; 2018 May; 75():10-15. PubMed ID: 29180251
[TBL] [Abstract][Full Text] [Related]
17. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma.
Aydin H; Young RH; Ronnett BM; Epstein JI
Am J Surg Pathol; 2005 Apr; 29(4):520-3. PubMed ID: 15767808
[TBL] [Abstract][Full Text] [Related]
18. Atypical Renal Cysts: A Morphologic, Immunohistochemical, and Molecular Study.
Matoso A; Chen YB; Rao V; Wang L; Cheng L; Epstein JI
Am J Surg Pathol; 2016 Feb; 40(2):202-11. PubMed ID: 26574846
[TBL] [Abstract][Full Text] [Related]
19. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
[TBL] [Abstract][Full Text] [Related]
20. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
